MedPath

EXEMED PHARMACEUTICALS

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

37

Active:0
Completed:32

Trial Phases

3 Phases

Phase 3:33
Phase 4:3
Not Applicable:1

Drug Approvals

19

PHILIPPINES:19

Drug Approvals

Exppra 500

Approval Date
Jul 14, 2025
PHILIPPINES

Apixar

Approval Date
Jul 14, 2025
PHILIPPINES

Imaglif

Approval Date
Jul 14, 2025
PHILIPPINES

Xrmin ER 1000.

Approval Date
Jul 14, 2025
PHILIPPINES

Medcarv 12.5

Approval Date
Jul 14, 2025
PHILIPPINES

Vilomet 500

Approval Date
Jul 14, 2025
PHILIPPINES

Vilomet

Approval Date
Jul 14, 2025
PHILIPPINES

Medcarv 6.25

Approval Date
Jul 14, 2025
PHILIPPINES

Medglor 90

Approval Date
Jul 14, 2025
PHILIPPINES

Daphix

Approval Date
Jul 14, 2025
PHILIPPINES
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials

Phase 3
33 (89.2%)
Phase 4
3 (8.1%)
Not Applicable
1 (2.7%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.